Product Images Myfembree
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Myfembree NDC 72974-415 by Sumitomo Pharma America, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - myfembree 01
Chemical Structure - myfembree 02
Chemical Structure - myfembree 03
Figure 1 L1 - myfembree 04
Figure 1 L2 - myfembree 05
The text represents a table showing the "Least Squares Mean Percent Change" of two groups (MYFEMBREE and Placebo) over a period of 24 weeks. The table includes values at baseline, week 4, week 12, week 16, week 20, and week 24. However, there is no indication about the nature of the percent change or the variable of interest, so any further interpretation is not possible.*
PRINCIPAL DISPLAY PANEL - 28 Tablet Bottle Label - myfembree 06
Myfembree is a prescription drug with NDC code 72974-415-01. It contains 40mg Relugolix, 1mg Estradiol, and 0.5mg Norethindrone Acetate per tablet. It comes in 28 tablets pack with dosages mentioned in the prescribing information. It is advised to store the medicine between 15°C to 30°C (59°F - 86°F). Myfembree is distributed by Myovant Sciences, Inc. based in Brisbane, CA, and manufactured in Canada. Please keep this medicine away from children and do not flush any unused medicine.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.